Flu Is Relentless. Crispr Might Be Able to Shut It Down Using Cas13
TL;DR Researchers are developing CRISPR-Cas13 systems delivered by lipid nanoparticles as a potential flu antiviral, aiming to cut viral RNA…
Wow News on Tech and AI
TL;DR Researchers are developing CRISPR-Cas13 systems delivered by lipid nanoparticles as a potential flu antiviral, aiming to cut viral RNA…